Form 4 for PCSA Processa Pharmaceuticals, Inc.
Accepted 2023-11-28 00:00:00 ET · period of report 2023-11-21 · accession 0000897069-23-001674 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-11-28 | 2023-11-21 | PCSA | Yorke Justin W | Dir | J - Other | $0.00 | -55.3K | 464.6K | -11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-21 | J | D | 55,267 | $0.00 | 464,623 | I By Richland Fund, LLC | — | — |